{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:45:55Z","timestamp":1777607155117,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.jsat.2010.03.003","type":"journal-article","created":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T04:39:43Z","timestamp":1270096783000},"page":"408-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: A pilot study"],"prefix":"10.1016","volume":"38","author":[{"given":"Eugenia","family":"Oviedo-Joekes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Guh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Brissette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohdan","family":"Nosyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aslam","family":"Anis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin T.","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2010.03.003_bib1","series-title":"Diagnostic and statistical manual of mental disorders DSM-IV","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.jsat.2010.03.003_bib2","series-title":"Report into the feasibility of trialling hydromorphone as a treatment for heroin dependence in the Australian Capital Territory","author":"Bammer","year":"2004"},{"key":"10.1016\/j.jsat.2010.03.003_bib3","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1016\/j.clpt.2003.11.008","article-title":"Comparison of heroin and hydromorphone in opioid users","volume":"75","author":"Brands","year":"2004","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.jsat.2010.03.003_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","article-title":"Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved","volume":"105","author":"Degenhardt","year":"2009","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.03.003_bib21","first-page":"CD004145","article-title":"Substitution treatment of injecting opioid users for prevention of HIV infection","volume":"2","author":"Gowing","year":"2008","journal-title":"Cochrane Database System Review"},{"key":"10.1016\/j.jsat.2010.03.003_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2006.03.007","article-title":"Behavioral economic analysis of opioid consumption in heroin-dependent individuals: Effects of unit price and pre-session drug supply","volume":"85","author":"Greenwald","year":"2006","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.03.003_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","article-title":"Heroin-assisted treatment for opioid dependence: Randomised controlled trial","volume":"191","author":"Haasen","year":"2007","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2010.03.003_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5694\/j.1326-5377.2002.tb04289.x","article-title":"Breaking the deadlock over an Australian trial of injectable opioid maintenance","volume":"176","author":"Hall","year":"2002","journal-title":"Medical Journal of Australia"},{"key":"10.1016\/j.jsat.2010.03.003_bib7","series-title":"Best practices in methadone maintenance treatment","author":"Health Canada","year":"2002"},{"key":"10.1016\/j.jsat.2010.03.003_bib8","series-title":"Guideline for good clinical practice. EMEA","author":"ICH Harmonised Tripartite Guideline","year":"2002"},{"key":"10.1016\/j.jsat.2010.03.003_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000259089","article-title":"EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence","volume":"1","author":"Kokkevi","year":"1995","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2010.03.003_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jsat.2006.04.007","article-title":"Controlled trial of prescribed heroin in the treatment of opioid addiction","volume":"31","author":"March","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2010.03.003_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2010.03.003_bib12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s11524-008-9312-9","article-title":"The North American Opiate Medication Initiative (NAOMI): Profile of participants in North America's First Trial of Heroin-Assisted Treatment","volume":"85","author":"Oviedo-Joekes","year":"2008","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.jsat.2010.03.003_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1740774509105222","article-title":"Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: Rationale and design of the NAOMI Study","volume":"6","author":"Oviedo-Joekes","year":"2009","journal-title":"Clinical Trials"},{"key":"10.1016\/j.jsat.2010.03.003_bib14","series-title":"Hydromorphone, product monograph","author":"Pharmascience Inc","year":"1996"},{"key":"10.1016\/j.jsat.2010.03.003_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-3565(24)38876-7","article-title":"Effects of agonist-antagonist opioids in humans trained in a hydromorphone\/not hydromorphone discrimination","volume":"295","author":"Preston","year":"2000","journal-title":"Journal of Pharmacology and Experimental Therapy"},{"key":"10.1016\/j.jsat.2010.03.003_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0885-3924(02)00643-7","article-title":"A systematic review of hydromorphone in acute and chronic pain","volume":"25","author":"Quigley","year":"2003","journal-title":"Journal of Pain Symptom Management"},{"key":"10.1016\/j.jsat.2010.03.003_bib17","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(01)06529-1","article-title":"Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: A follow-up study","volume":"358","author":"Rehm","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2010.03.003_bib22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbi.2007.12.013","article-title":"Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function","volume":"22","author":"Sacerdote","year":"2008","journal-title":"Brain Behavior & Immunity"},{"key":"10.1016\/j.jsat.2010.03.003_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s002130100920","article-title":"Blockade of hydromorphone effects by buprenorphine\/naloxone and buprenorphine","volume":"159","author":"Strain","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jsat.2010.03.003_bib19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bmj.327.7410.310","article-title":"Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials","volume":"327","author":"van den Brink","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jsat.2010.03.003_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(90)91102-O","article-title":"Clinical analgesic assay of repeated and single doses of heroin and hydromorphone","volume":"41","author":"Wallenstein","year":"1990","journal-title":"Pain"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547210000632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547210000632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:34:10Z","timestamp":1760038450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547210000632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0740547210000632"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2010.03.003","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2010.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}